Marcus Hjort1, Bertil Lindahl2, Tomasz Baron2, Tomas Jernberg3, Per Tornvall4, Kai M Eggers5. 1. Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden; Department of Medical Sciences, Uppsala University, Uppsala, Sweden. Electronic address: marcus.hjort@medsci.uu.se. 2. Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden; Department of Medical Sciences, Uppsala University, Uppsala, Sweden. 3. Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden. 4. Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden. 5. Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Abstract
BACKGROUND: Myocardial infarction (MI) with non-obstructive coronary arteries (MINOCA) is a recently recognized condition where biomarkers and prognosis are less well studied than in MI with obstructive coronary artery disease (MI-CAD). We therefore aimed to investigate the one-year prognostic value of high-sensitivity cardiac troponin T (hs-cTnT) levels in MINOCA in comparison to MI-CAD. METHODS: In this registry-based cohort study, we used data from patients with a discharge diagnosis of MI, admitted between 2009 and 2013 to Swedish hospitals using the hs-cTnT assay. Only patients without previously known coronary artery disease were considered. Patients with and without coronary stenosis >50% were regarded to have MI-CAD and MINOCA, respectively. Assessed outcomes included all-cause mortality, cardiovascular (CV) mortality and major CV events (MACE), defined as the composite of CV death or admissions for non-fatal MI, heart failure (HF) or ischemic stroke. RESULTS: The study cohort consisted of 1639 MINOCA and 17,304 MI-CAD patients. In adjusted analyses, hs-cTnT (ln) in MINOCA patients predicted all-cause mortality (HR 1.32 [95% CI 1.11-1.56]), CV mortality (HR 2.11 [95% CI 1.51-2.96]) and MACE (HR 1.44 [95% CI 1.20-1.72]). Hs-cTnT (ln) also predicted readmissions for HF (HR 1.51 [95% CI 1.51-2.96]) but not non-fatal MI or stroke. Interaction analyses suggested that hs-cTnT (ln) was at least as prognostic in patients with MINOCA compared to MI-CAD. CONCLUSIONS: Hs-cTnT levels in MINOCA patients are strong and independent predictors of adverse outcome. Consideration of hs-cTnT levels is important for risk assessment of MINOCA patients.
BACKGROUND:Myocardial infarction (MI) with non-obstructive coronary arteries (MINOCA) is a recently recognized condition where biomarkers and prognosis are less well studied than in MI with obstructive coronary artery disease (MI-CAD). We therefore aimed to investigate the one-year prognostic value of high-sensitivity cardiac troponin T (hs-cTnT) levels in MINOCA in comparison to MI-CAD. METHODS: In this registry-based cohort study, we used data from patients with a discharge diagnosis of MI, admitted between 2009 and 2013 to Swedish hospitals using the hs-cTnT assay. Only patients without previously known coronary artery disease were considered. Patients with and without coronary stenosis >50% were regarded to have MI-CAD and MINOCA, respectively. Assessed outcomes included all-cause mortality, cardiovascular (CV) mortality and major CV events (MACE), defined as the composite of CV death or admissions for non-fatal MI, heart failure (HF) or ischemic stroke. RESULTS: The study cohort consisted of 1639 MINOCA and 17,304 MI-CADpatients. In adjusted analyses, hs-cTnT (ln) in MINOCA patients predicted all-cause mortality (HR 1.32 [95% CI 1.11-1.56]), CV mortality (HR 2.11 [95% CI 1.51-2.96]) and MACE (HR 1.44 [95% CI 1.20-1.72]). Hs-cTnT (ln) also predicted readmissions for HF (HR 1.51 [95% CI 1.51-2.96]) but not non-fatal MI or stroke. Interaction analyses suggested that hs-cTnT (ln) was at least as prognostic in patients with MINOCA compared to MI-CAD. CONCLUSIONS: Hs-cTnT levels in MINOCA patients are strong and independent predictors of adverse outcome. Consideration of hs-cTnT levels is important for risk assessment of MINOCA patients.
Authors: Rachel P Dreyer; Rosanna Tavella; Jeptha P Curtis; Yongfei Wang; Sivabaskari Pauspathy; John Messenger; John S Rumsfeld; Thomas M Maddox; Harlan M Krumholz; John A Spertus; John F Beltrame Journal: Eur Heart J Date: 2020-02-14 Impact factor: 35.855
Authors: Ahmed AlBadri; Janet Wei; Odayme Quesada; Puja K Mehta; Yi Xiao; Yi-An Ko; R David Anderson; John Petersen; Babak Azarbal; Bruce Samuels; Timothy D Henry; Galen Cook-Wiens; Eileen M Handberg; Jennifer Van Eyk; Carl J Pepine; C Noel Bairey Merz Journal: Arterioscler Thromb Vasc Biol Date: 2020-10-08 Impact factor: 10.514
Authors: T F S Pustjens; Y Appelman; P Damman; J M Ten Berg; J W Jukema; R J de Winter; W R P Agema; M L J van der Wielen; F Arslan; S Rasoul; A W J van 't Hof Journal: Neth Heart J Date: 2020-03 Impact factor: 2.380